ArticleGynecologic oncology reports2026

Successful use of immune checkpoint Inhibition in a patient with myasthenia gravis and recurrent endometrial cancer- expanding access beyond initial clinical trial eligibility.

Olivia N Julian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.